Cell & Gene Therapy Trials: Patient Identification (Chapter 3 of 5)

Adam Callahan examines why identifying suitable patients is critical in cell and gene therapy trials. He discusses how clinical databases, patient advocacy networks, academic institutions, and community-based practices can help locate potential candidates across North America, Europe, and the Asia-Pacific region. Investigators and site physicians then work directly with patients to determine whether participation may be appropriate. Adam also explains how electronic medical records, claims information, diagnostic data, precision medicine, and next-generation sequencing are refining this process. Together, these clinical relationships and technological capabilities can support earlier and more focused identification of potential trial participants.